Irritable Bowel Syndrome (IBS) and Histopathological Changes

Estimated Read Time: Approximately 9 minutes

Keywords: IBS, Histopathologic, Histopathological Changes, Inflammatory, Mast Cells, Enteric Nerves, Enterochromaffin Cells, Chronic Inflammation, Immune Activation, Pathophysiology, Gastrointestinal, T-lymphocytes, PI-IBS, Visceral Stimuli (11)

Study Authors: Richard H. Kirsch and Robert Riddell

This article is a summary and written based on the study in the following link.

Irritable bowel syndrome (IBS) is a prevalent gastrointestinal disorder characterized by abdominal pain and altered bowel habits. Its multifactorial etiopathogenesis includes altered gastrointestinal motor function, enhanced perception of visceral stimuli, and psychosocial factors. Recently, mucosal immune activation has been implicated. While routine histologic examinations often show no mucosal abnormalities, advanced histological, immunohistochemical, and ultrastructural analyses have revealed subtle morphologic changes involving lymphocytes, mast cells, enterochromaffin cells, and enteric nerves. These findings suggest new links between the central and enteric nervous systems and immune processes.

IBS Diagnosis and Subtypes

IBS affects 10-20% of adolescents and adults in Western societies, and is the most common cause of recurrent abdominal pain in children. Diagnosed based on symptomatology, several criteria, including the Manning, Rome I, Rome II, and Rome III criteria, have been developed. These criteria have shown reasonable sensitivity and specificity, with the Rome criteria having a positive predictive value of approximately 98%. IBS is subclassified into diarrhea-predominant, constipation-predominant, and mixed subtypes. Some patients experience extraintestinal symptoms such as fatigue, fibromyalgia, urinary frequency, and headache. A subset of IBS patients report symptom onset following acute gastroenteritis, known as post-infectious IBS (PI-IBS).

Histological Findings in IBS

Routine histologic examinations often reveal no significant colonic mucosal abnormalities. However, recent studies have shown:

Chronic Inflammatory Cells: Increased numbers of T-lymphocytes in the lamina propria and epithelial layers.
Mast Cells: Increased mast cell density, particularly in diarrhea-predominant IBS, with mast cells often located near enteric nerves.
Enterochromaffin Cells (EC): Increased EC cell numbers, especially in PI-IBS.
Enteric Nerves: Increased nerve fibers staining for neuron-specific enolase, substance P, and 5-HT, with closer proximity to mast cells and lymphocytes in IBS patients.

Pathophysiological Implications

The modest increases in inflammatory cells and their potential for cytokine production suggest immune activation in IBS. The proximity of chronic inflammatory cells to enteric nerves provides an interface for direct interaction, potentially linking immune and nervous system processes. Reports of increased mast cell numbers and degranulation, along with increased spontaneous release of mast cell mediators, indicate a role for mast cells in disturbed sensorimotor functions in IBS.

Clinical Relevance

While the precise relationship between these histopathologic changes and IBS pathogenesis remains unclear, recognizing these subtle changes enhances our understanding of IBS. Quantitative analyses have uncovered significant mucosal abnormalities, suggesting that routine histopathological assessment may underestimate the extent of changes present.

Conclusion

IBS involves a complex symptomatology with multifactorial etiopathogenesis. Recent studies highlight the role of immune activation and neuro-immune interactions in IBS. Although routine pathology practices may not yet incorporate these findings, understanding the subtle histopathologic changes in IBS patients can provide valuable insights into its pathophysiology and potential treatment strategies. Visit our resources for more articles.

References

Olden KW. Diagnosis of irritable bowel syndrome. Gastroenterology 2002;122:1701–1704.
Mitchell CM, Drossman DA. Survey of the AGA membership relating to patients with functional gastrointestinal disorders. Gastroenterology 1987;92:1282–1284.
Ringel Y, Drossman DA. Irritable bowel syndrome: classification and conceptualization. J Clin Gastroenterol 2002;35:S7–S10.
El-Matary W, Spray C, Sandhu B. Irritable bowel syndrome: the commonest cause of recurrent abdominal pain in children. Eur J Pediatr 2004;163:584–588.
Lembo TJ, Fink RN. Clinical assessment of irritable bowel syndrome. J Clin Gastroenterol 2002;35: S31–S36.
Drossman DA. The functional gastrointestinal disorders and the Rome III process. Gastroenterol 2006;130:1377–1390. Spiller RC. Postinfectious irritable bowel syndrome. Gastroenterol 2003;124:1662–1671.
Wang LH, Fang XC, Pan GZ. Bacillary dysentery as a causative factor of irritable bowel syndrome and its pathogenesis. Gut 2004;53:1096–1101.
Spiller R, Campbell E. Post-infectious irritable bowel syndrome. Curr Opin Gastroenterol 2006;22:13–17.
McKendrick MW. Post Salmonella irritable bowel syndrome—5 year review. J Infect 1996;32:170–171.
Spiller RC, Jenkins D, Thornley JP, et al. Increased rectal mucosal enteroendocrine cells, T lymphocytes, and increased gut permeability following acute Campylobacter enteritis and in post-dysenteric irritable bowel syndrome. Gut 2000;47:804–811.
Gwee KA, Leong YL, Graham C, et al. The role of psychological and biological factors in postinfective gut dysfunction. Gut 1999;44:400–406.

See original study for ALL references